Explore new perspectives in research
Hello n.able!
n.able is a spin-off company born at the Institute of Nanotechnology, Karlsruhe Institute of Technology in Germany. In 2018 we were supported by the Helmholtz Association which helped us to successfully finalise our product development.
We have applied our 10 years of experience in functionalization of surfaces at nano- and microscales to develop an innovative Molecular Desktop Printer. Our printer is designed for fast surface and device functionalization with a huge variety of inks. Having our customers in mind, we have made our Printer fully customisable with a flexible choice of modules.
Thanks to our innovative printer and its numerous possibilities to functionalise surfaces, we open horizons for innovative processes and solutions. Experts in biology, clinical diagnostics or material science will find our printer to be an easy to use, time and cost effective fabrication tool.
We don‘t just offer new perspectives – we n.able new ones. Explore yours with our Molecular Desktop Printer.
Opening horizons in research
Thanks to our innovative products and numerous possibilities for functionalising surfaces, we open up new perspectives for research and industry. We enable new processes and solutions for clinical diagnostics, personalized medicine or material science.
We call it revolutionizing research.
Our products
Molecular Desktop Printer
- Automated printing modes
- Printing on dm²
- Ink multiplexing (up to 12 inks)
- Environmental chamber
Consumables
- Probes
- Multifunctional probe holder
- Printing kits for proteins
Services
- Consulting
- Contract R&D projects
- Cooperation projects
Discover your applications
Our molecular printer offers great possibilities for the fabrication of (bio)functional arrays, molecular sensors and lab-on-a-chip platforms. It is a powerful tool for biological and medical research, as well as material science.
Switchover between soft-lithography-based printing modes allows for a high degree of flexibility during sample fabrication.
Automation of printing of single or multiplexed patterns makes our printer very easy to operate.
Biology and medicine research
Multiplexed cell arrays
A novel approach for integration of more than one ink in an interdigitaed pattern was achived by polymer pen lithography. This new inking and writing strategy was applied to immobilize functional proteins for cell studies.
Multicomponent single cell arrays
Click-chemistry approach was used to create multi-component arrays. Pattern size of 10 – 20 µm was demonstrated to be very efficient in capturing cells into single cell in arrays.
Multiplexed phospholipid arrays for protein binding
High resolution phospholipid patters are used for binding of proteins and cell-surface interaction studies.
Hybridization on multiplexed oligonucleotide arrays
Immobilization of oligonucleotides into arrays was done using polmer pen lithography. Those binding tags were used to monitor cell-protein interaction.
Photonics and material research
Optical microcavities for biosensing
Microcontact stamping was utilized to coat the circumferences of goblet-shaped optical microcavities in a parallel but still highly localized manner. By using multicomponent
phospholipid inks, biorecognition elements as well as lasing components can be implemented, to realize multifunctional microlaser arrays for biosensing applications.
Highly controlled growth of carbon nanofibers
Cantilever-based printing was utilized to highly control the growth of carbon nanofibers (CNFs). The unique lateral resolution of this technique allowed for precise dosing
of a NiCl-based growth catalyst – resulting in “two-legged” fibers, so-called lambda-CNFs, in defined densities, down to single fibers.
Our company
n.able was founded in 2019 as a spin-off at Institute of Nanotechnology, Karlsruhe Institute of Technology.
We are a young team of scientists and business professional with more than 10 years of experience in the field of surface functionalization in the micro- and nano-scale.
We have developed our Molecular Printer with scientist in mind for: fast, automated and multifunctional deposition of inks on various surfaces.
Our core team
Martin Vallon
Physicist
CEO
Dr. Sylwia Sekula-Neuner
Molecular biologist
CMO
Dr. Uwe Bog
Electrical engineer
CTO
News and events
Find out more about our company and activities:
28.05.2019 – Founding of n.able
The myPrint spin-off project becomes n.able and is now formally incorporated.
07.12.2018 – CAREER DAY Entrepreneurship & (Bio)Tech
Are you looking for the next step in your career? Meet n.able at the German Cancer Research Center (DKFZ).
27.06.2018 – Neuland Innovation day
We we presenting our start up at the Neuland Innovation days at Karlsruhe Institute of Technology. We were pitching our business idea in front of the investors and presented our product to visitors from various industries. We could also meet other start-up founders and learn about their innovative ideas.
13.06.2018 – upCAT Accelerator Program
We took part in the accelerator program upCAT (Startup Catalyst). Together with upCAT team we worked on our business model, value proposition and market entry. During the final presentation at the DemoDay Dr.-Ing. Uwe Bog gave a pitch on our company idea.
We also had a chance to network, meet other start-up founders, mentors and investors.
21.03.2018 – Hannover Fair Trade
We had a unique opportunity to present our stat-up at the Hannover Fair Trade (Hannover Messe) in front of hundreds of visitors. We had a chance to network with potential investors and meet other start-up founders from various disciplines.
Our stand was also visited by Prof. Thomas Hirth (on the left), Vice-President for Innovation and International Affairs at Karlsruhe Institute of Technology.
17.01.2018 – Helmholtz Enterprise
myPrint gets funded by the Helmholtz Association of German Research Centers within their Helmholtz Enterprise program.
Enable your visions now
If you would like to have more information on our innovative Molecular Desktop Printer or our services, please contact us:
Dr. Sylwia Sekula-Neuner
E ssn@n-able-innovation.com
T +49 (0)721 608-28897